Katherine K Tassiopoulos, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 66 | 2024 | 17354 | 2.120 |
Why?
|
Infectious Disease Transmission, Vertical | 13 | 2022 | 1352 | 0.870 |
Why?
|
Meconium | 4 | 2015 | 47 | 0.720 |
Why?
|
HIV Integrase Inhibitors | 4 | 2023 | 165 | 0.700 |
Why?
|
Condoms | 3 | 2021 | 331 | 0.670 |
Why?
|
Anti-HIV Agents | 15 | 2023 | 4527 | 0.630 |
Why?
|
Sexual Behavior | 6 | 2021 | 2180 | 0.570 |
Why?
|
Substance Abuse Detection | 4 | 2010 | 301 | 0.550 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2017 | 1897 | 0.540 |
Why?
|
Accidental Falls | 4 | 2024 | 1068 | 0.510 |
Why?
|
Cocaine-Related Disorders | 4 | 2006 | 461 | 0.480 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2022 | 2151 | 0.460 |
Why?
|
Needle Sharing | 1 | 2013 | 22 | 0.460 |
Why?
|
Viral Load | 9 | 2020 | 3332 | 0.450 |
Why?
|
Dangerous Behavior | 1 | 2012 | 65 | 0.410 |
Why?
|
Frail Elderly | 1 | 2017 | 765 | 0.380 |
Why?
|
Hair | 2 | 2006 | 498 | 0.380 |
Why?
|
Data Collection | 1 | 2020 | 3322 | 0.380 |
Why?
|
Lymphocyte Subsets | 1 | 2012 | 309 | 0.370 |
Why?
|
Anti-Retroviral Agents | 7 | 2024 | 1784 | 0.350 |
Why?
|
Heroin Dependence | 3 | 2005 | 172 | 0.330 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 529 | 0.320 |
Why?
|
Self Disclosure | 3 | 2006 | 249 | 0.310 |
Why?
|
Medication Adherence | 5 | 2020 | 2176 | 0.290 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2019 | 2518 | 0.270 |
Why?
|
Health Behavior | 2 | 2016 | 2644 | 0.260 |
Why?
|
HIV Protease Inhibitors | 1 | 2008 | 432 | 0.250 |
Why?
|
Herpes Genitalis | 1 | 2007 | 150 | 0.250 |
Why?
|
Herpesvirus 2, Human | 1 | 2007 | 191 | 0.250 |
Why?
|
Adolescent | 32 | 2023 | 88326 | 0.240 |
Why?
|
Hypercholesterolemia | 2 | 2011 | 1141 | 0.240 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4420 | 0.240 |
Why?
|
Papillomavirus Vaccines | 2 | 2022 | 496 | 0.230 |
Why?
|
Longitudinal Studies | 10 | 2022 | 14608 | 0.230 |
Why?
|
Occupations | 1 | 2006 | 515 | 0.220 |
Why?
|
Restaurants | 1 | 2006 | 231 | 0.220 |
Why?
|
Female | 64 | 2024 | 392705 | 0.220 |
Why?
|
Male | 55 | 2024 | 360846 | 0.210 |
Why?
|
Trichomonas Infections | 1 | 2022 | 41 | 0.210 |
Why?
|
Social Perception | 1 | 2006 | 433 | 0.200 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 70 | 0.200 |
Why?
|
Cocaine | 2 | 2006 | 958 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4580 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3206 | 0.200 |
Why?
|
Cohort Studies | 19 | 2024 | 41495 | 0.200 |
Why?
|
Adult | 35 | 2024 | 221210 | 0.190 |
Why?
|
Polypharmacy | 1 | 2024 | 306 | 0.190 |
Why?
|
Self Report | 3 | 2016 | 3725 | 0.190 |
Why?
|
Prevalence | 13 | 2022 | 15733 | 0.190 |
Why?
|
Middle Aged | 32 | 2024 | 220921 | 0.190 |
Why?
|
Diabetes Mellitus | 4 | 2024 | 5841 | 0.180 |
Why?
|
Succinic Acid | 1 | 2021 | 86 | 0.180 |
Why?
|
Cholesterol | 2 | 2019 | 2905 | 0.180 |
Why?
|
Humans | 72 | 2024 | 761596 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4369 | 0.180 |
Why?
|
Syphilis | 1 | 2022 | 243 | 0.170 |
Why?
|
Aging | 6 | 2022 | 8710 | 0.170 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2199 | 0.170 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15502 | 0.170 |
Why?
|
Drug Resistance, Viral | 2 | 2016 | 862 | 0.160 |
Why?
|
Chlamydia Infections | 1 | 2022 | 365 | 0.160 |
Why?
|
Risk Factors | 20 | 2024 | 74213 | 0.160 |
Why?
|
Hepatitis C | 2 | 2023 | 1584 | 0.160 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1613 | 0.160 |
Why?
|
Mental Disorders | 5 | 2019 | 6845 | 0.160 |
Why?
|
Young Adult | 14 | 2022 | 59260 | 0.160 |
Why?
|
Tanzania | 3 | 2009 | 1390 | 0.160 |
Why?
|
Gonorrhea | 1 | 2022 | 346 | 0.150 |
Why?
|
HIV | 5 | 2023 | 1582 | 0.150 |
Why?
|
Prediabetic State | 1 | 2024 | 545 | 0.150 |
Why?
|
DNA, Mitochondrial | 2 | 2021 | 865 | 0.150 |
Why?
|
United States | 17 | 2021 | 72340 | 0.150 |
Why?
|
Prospective Studies | 16 | 2023 | 54423 | 0.150 |
Why?
|
Hepatitis B | 1 | 2023 | 705 | 0.140 |
Why?
|
Child | 22 | 2022 | 80158 | 0.140 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 662 | 0.140 |
Why?
|
HIV-1 | 4 | 2021 | 6863 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2023 | 683 | 0.130 |
Why?
|
Logistic Models | 6 | 2020 | 13255 | 0.130 |
Why?
|
Bone Diseases | 1 | 2019 | 418 | 0.130 |
Why?
|
Antibodies, Viral | 2 | 2019 | 3156 | 0.130 |
Why?
|
Age Factors | 8 | 2019 | 18399 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2571 | 0.120 |
Why?
|
Metformin | 1 | 2023 | 906 | 0.120 |
Why?
|
Puerto Rico | 1 | 2016 | 376 | 0.120 |
Why?
|
Aged | 14 | 2024 | 169310 | 0.120 |
Why?
|
Safe Sex | 2 | 2021 | 144 | 0.120 |
Why?
|
Pregnancy | 14 | 2022 | 29890 | 0.120 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.120 |
Why?
|
Risk-Taking | 2 | 2011 | 1038 | 0.110 |
Why?
|
Odds Ratio | 7 | 2021 | 9647 | 0.110 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 888 | 0.110 |
Why?
|
Health Services | 1 | 2019 | 752 | 0.110 |
Why?
|
Haplotypes | 1 | 2020 | 2713 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1119 | 0.110 |
Why?
|
Treatment Failure | 1 | 2019 | 2643 | 0.110 |
Why?
|
Aged, 80 and over | 6 | 2023 | 58984 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2005 | 395 | 0.100 |
Why?
|
Prenatal Injuries | 1 | 2012 | 13 | 0.100 |
Why?
|
Weight Gain | 4 | 2024 | 2348 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2015 | 7828 | 0.100 |
Why?
|
HIV Seropositivity | 2 | 2019 | 960 | 0.100 |
Why?
|
Sex Offenses | 1 | 2016 | 352 | 0.100 |
Why?
|
Fractures, Bone | 2 | 2015 | 2046 | 0.100 |
Why?
|
Crime Victims | 1 | 2016 | 347 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39106 | 0.100 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 26129 | 0.100 |
Why?
|
Caregivers | 4 | 2019 | 2238 | 0.100 |
Why?
|
Bone Resorption | 1 | 2015 | 723 | 0.090 |
Why?
|
Bone Density | 2 | 2015 | 3551 | 0.090 |
Why?
|
Unsafe Sex | 1 | 2012 | 238 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2022 | 26202 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1782 | 0.090 |
Why?
|
Marijuana Smoking | 1 | 2013 | 258 | 0.090 |
Why?
|
Demography | 3 | 2019 | 1648 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 2 | 2015 | 1188 | 0.090 |
Why?
|
Integrases | 2 | 2023 | 518 | 0.090 |
Why?
|
Pregnancy Trimesters | 1 | 2010 | 197 | 0.080 |
Why?
|
Gestational Age | 2 | 2015 | 3577 | 0.080 |
Why?
|
Body Size | 1 | 2012 | 463 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1475 | 0.080 |
Why?
|
Antibodies, Bacterial | 1 | 2014 | 1469 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3093 | 0.080 |
Why?
|
Counseling | 1 | 2016 | 1547 | 0.080 |
Why?
|
Incidence | 6 | 2019 | 21355 | 0.070 |
Why?
|
Alcohol Drinking | 2 | 2013 | 4028 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8633 | 0.070 |
Why?
|
Population Surveillance | 2 | 2016 | 2598 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13510 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 609 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12463 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1392 | 0.070 |
Why?
|
Adenine | 1 | 2012 | 987 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1139 | 0.070 |
Why?
|
Adolescent Behavior | 2 | 2013 | 1190 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2684 | 0.060 |
Why?
|
Motivation | 2 | 2006 | 2006 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8466 | 0.060 |
Why?
|
Cognition | 4 | 2023 | 6992 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5485 | 0.060 |
Why?
|
Psychology | 1 | 2006 | 356 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.060 |
Why?
|
Sexual Partners | 1 | 2009 | 796 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2004 | 861 | 0.050 |
Why?
|
Mothers | 1 | 2014 | 2198 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2019 | 4481 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2012 | 2161 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 1213 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 23996 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2009 | 2079 | 0.050 |
Why?
|
Child, Preschool | 7 | 2016 | 42232 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5890 | 0.050 |
Why?
|
Benzoxazines | 1 | 2023 | 316 | 0.050 |
Why?
|
Inflammation | 3 | 2023 | 10774 | 0.050 |
Why?
|
Comorbidity | 3 | 2024 | 10508 | 0.050 |
Why?
|
Citric Acid | 1 | 2021 | 123 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2022 | 239 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4758 | 0.050 |
Why?
|
Cultural Diversity | 1 | 2005 | 369 | 0.050 |
Why?
|
Massachusetts | 1 | 2013 | 8833 | 0.050 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 983 | 0.040 |
Why?
|
Neisseria gonorrhoeae | 1 | 2022 | 239 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2023 | 603 | 0.040 |
Why?
|
Infant | 7 | 2016 | 36193 | 0.040 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.040 |
Why?
|
Condylomata Acuminata | 1 | 2019 | 75 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2023 | 675 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2023 | 528 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16592 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4431 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29629 | 0.040 |
Why?
|
RNA, Viral | 2 | 2019 | 2846 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2947 | 0.030 |
Why?
|
Maternal Exposure | 2 | 2015 | 1067 | 0.030 |
Why?
|
Developing Countries | 1 | 2009 | 2885 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 3980 | 0.030 |
Why?
|
Attitude to Health | 1 | 2005 | 2025 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9053 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2019 | 570 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10554 | 0.030 |
Why?
|
Decision Making | 1 | 2009 | 3929 | 0.030 |
Why?
|
Hepatitis A Vaccines | 1 | 2014 | 26 | 0.030 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.030 |
Why?
|
Domestic Violence | 1 | 2016 | 182 | 0.030 |
Why?
|
Tetanus Toxoid | 1 | 2014 | 189 | 0.030 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 804 | 0.030 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2019 | 600 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2725 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1188 | 0.030 |
Why?
|
Mental Health Services | 1 | 2005 | 1730 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2050 | 0.030 |
Why?
|
Postpartum Period | 1 | 2019 | 1175 | 0.030 |
Why?
|
Boston | 1 | 2006 | 9327 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1315 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 583 | 0.030 |
Why?
|
Mexico | 1 | 2015 | 764 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 778 | 0.030 |
Why?
|
Mood Disorders | 1 | 2019 | 1127 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 4016 | 0.020 |
Why?
|
Peru | 1 | 2015 | 891 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2023 | 1940 | 0.020 |
Why?
|
Brazil | 1 | 2015 | 1230 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 437 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2011 | 461 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 1 | 2012 | 461 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2639 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12953 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2902 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2421 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7054 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2014 | 1359 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2720 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2012 | 870 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 924 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12149 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12059 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 64685 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22176 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9319 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3250 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.010 |
Why?
|
Urban Health | 1 | 2005 | 532 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6312 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 39969 | 0.010 |
Why?
|
Child Development | 1 | 2012 | 2306 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3208 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4352 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10451 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3826 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30053 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6180 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2010 | 3407 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14033 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14665 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 80647 | 0.000 |
Why?
|